370 likes | 1.2k Views
Osteoporosis. Excessive skeletal fragility leading to low trauma fractures. Intrinsic skeletal factors: low bone mass, unfavorable geometry at cortical bone sites, small bone size, poor bone structure at cancellous bone sites and sluggish or ineffective repair of microdamage.
E N D
Osteoporosis • Excessive skeletal fragility leading to low trauma fractures. • Intrinsic skeletal factors: low bone mass, unfavorable geometry at cortical bone sites, small bone size, poor bone structure at cancellous bone sites and sluggish or ineffective repair of microdamage. • Extrinsic factors: propensity to fall.
Osteoporosis • 1.7 million hip fractures 1990 • 6.3 million hip fractures 2050 • 40% of postmenopausal women, on average, will suffer at least one osteoporotic fracture • Osteoporosis incurs ~14 billion dollars in the US alone in 1997
WHO Criteria:bone mass values that is >2.5 SD below the young adult mean value. BMD (bone mineral density):measured by techniques such as DXA (dual energy x-ray absorptiometry).
Determination of BMD • By environmental factors(individual factors as well as E x E interaction) (Smoking, nutrition, exercises, diseases, medication, alcohol consumption etc.) ~15-45%. • By genetic factors • (individual genes as well as epistasis) ~55-85%. • By G x E Interaction~ ? %.
Segregation analyses • No major genes: (Guegen et al., 1995); • Major genes: (Livshits et al., 1996; 1999; 2002; Cardon et al., 2000; Deng et al., 2002; Liu et al., 2003a, b).
Genetic correlation • Significant between BMD at different sites (Pocock et al., 1987; Nguyen et al., 1998; Deng et al., 1999; Kobyliansky et al., 2000); • Not significant between BMD and osteoporotic fractures (OF) (Deng et al., 2002). At hip, • h2 BMD: 0.65, h2 OF: 0.53; • genetic correlation between BMD and OF: 0.05.
Goals of Molecular Genetics of Osteoporosis • To identify genes for risk of osteoporotic fractures • develop molecular genetic markers for diagnosis, prevention, early intervention, and individualized treatment • study molecular and cell functions of mutations of genes identified for development of drug and effective treatment
Approaches • Association studies • Linkage studies • Transmission Disequilibrium Test (TDT) • QTL mapping in mice • gene expression studies • Proteomics
VDR Gene (12q12-14) • VD modulates intestinal calcium absorption, osteoclastic and osteoblastic activities, PTH production. • VDR mediates the biological actions of 1,25(OH)2D3. • Mutations in VDR gene cause hereditary vitamin D-resistant rickets. • VDR gene knockout mice possess low bone mass, hypocalcemia, and hyperparathyroidism.
Morrison et al. (1994): a significant association between the Bsm I polymorphism and BMD. • Meta-analyses: BMD is associated with VDR gene (Cooper et al., 1996; Gong et al., 1999). Cdx-2 Taq I RFLP
ER-Gene (6q25) • ER-mediates the physiologic effects of the estrogen. • ER- expression found in human osteoblasts and osteoclasts. • Estrogen resistance due to a nonsense mutation in ER- gene causes severe osteoporosis (Smith et al. 1994).
Sano et al. (1995): associations between the TA repeat polymorphism and BMD in Japanese women. • Meta-analysis: Xba I polymorphism is associated with BMD and OF(Ioannidis et al., 2002).
COLIA1 Gene(17q21-q22) • COLIA1 gene encodes the 1(I) protein chain of type I collagen, the most abundant extracellular bone matrix protein. • Mutations in the coding regions of the COLIA1 gene result in osteogenesis imperfecta. • COLIA1 knock-out mice exhibits low bone mass and high risk fractures.
Grant et al. (1996) described an association between a GT polymorphism in a binding motif for Sp1 with BMD and OF. • Meta-analysis: Sp1 polymorphism is associated with BMD and OF (Mann et al., 2001; Efstathiadou et al., 2001). • Sp1 polymorphism may be functional (Mann et al., 2001).
TDT of candidate genes • TGF-1 gene (hip BMD)(Keen et al., 2001); • VDR (hip BMD), BGP (spine BMD) and PTH genes (Deng et al., 2002) • BGP gene (spine BMD and ultrasound measurements of bone) (Andrew et al., 2002); • ER- gene(hip and spine BMD)(Qin et al., 2003).
Interaction studies • ER- and VDR genes for BMD (Willings et al., 1998); • VDR and COL1a1 genes for OF (Uitterlinden et al. 2001); • VDR gene and Ca2+ intake for BMD change (Ferrari et al., 1995; Krall et al., 1995; Kiel et al., 1997); • ER- and VDR genes for BMD change during HRT(Deng et al., 1998).
Genetic basis of racial differentiation • VDR BsmI and hip OF (Young et al., 1996). • Sp1 and RsaI of Col1a1,–174G/C of IL-6, Asn363Ser of GR, and the T->C of TGF- 1(Lei et al., 2002). • BsaHI of CASR, SacI of AHSG, PvuII and XbaI ER-α, ApaI VDR, and BstBI PTH (Dvornyk et al., 2003).